Bioten Co., Ltd. (XKON:289170)
South Korea
· Delayed Price · Currency is KRW 3,695.00
-90.00 (-2.38%)
At close: Mar 9, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 13.22 billion as of March 9, 2026. Its market cap has decreased by -28.94% in one year.
Market Cap
13.22B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
11.23
Stock Price
3,695.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 13.22B, a decrease of -43.91%. That is a compound annual growth rate of -21.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 13.22B | 3.79% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CXI Healthcare Technology Group | 12.38B |
| Future Medicine | 15.61B |
| Kwangdong Healthbio | 18.02B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 20.63B |
| BIFIDO | 23.27B |
| Daesung Microbiological Labs. | 24.09B |
| ChoA Pharmaceutical Co., LTD. | 26.98B |